Dr. Grey AI

Hepatic Encephalopathy

Hepatic encephalopathy refers to a deterioration in brain function in people with severe liver disease. It occurs because the liver is unable to remove toxins from the blood. Symptoms include confusion, forgetfulness, personality changes, and sluggish movement and speech.

Quick Answer

What it is

Hepatic encephalopathy refers to a deterioration in brain function in people with severe liver disease. It occurs because the liver is unable to remove toxins from the blood.

Key findings

  • Grade A: Ammonia (L-Carnitine)
  • Grade B: Blood Urea Nitrogen (BUN) (Resveratrol)
  • Grade N/A: Serum Albumin (Resveratrol)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Hepatic Encephalopathy

  • Supplements Studied:2
  • Research Trials:7
  • Total Participants:1,118
  • Grade A Supplements:1
  • Top Supplement:L-Carnitine (A)
7 trials
1,118 ppts
2 supps · 15 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

L-Carnitine (LOLA alternative)A
1-2g L-carnitine daily or 9-18g LOLA daily

Enhances ammonia detoxification and provides neuroprotection; L-ornithine L-aspartate (LOLA) is the standard form studied for HE

15 studies | 1,000 participants
Branched-Chain Amino Acids (BCAAs)B
0.25g/kg/day or as directed

Compete with aromatic amino acids for brain uptake; may improve mental status and protein tolerance

12 studies | 800 participants

Supporting Stack (Tier 2)

ZincB
50-150mg daily (as zinc sulfate)

Cofactor for urea cycle enzymes; deficiency common in cirrhosis; supplementation may reduce ammonia levels

10 studies | 500 participants
ProbioticsB
Multi-strain formula, 10-50 billion CFU daily

Reduce ammonia-producing gut bacteria; decrease intestinal ammonia absorption and systemic inflammation

15 studies | 1,000 participants
ResveratrolB
150-500mg daily

Neuroprotective antioxidant; may reduce oxidative stress and inflammation in hepatic encephalopathy

6 studies | 250 participants
Vitamin DC
2000-4000 IU daily (based on levels)

Deficiency extremely common in liver disease; associated with worse outcomes; supplementation may support brain function

8 studies | 400 participants
Omega-3 Fatty AcidsC
1-2g EPA+DHA daily

Anti-inflammatory effects may reduce systemic inflammation contributing to encephalopathy

6 studies | 300 participants

How It Works

Hepatic encephalopathy (HE) is a brain dysfunction caused by liver disease. When the liver can't properly detoxify blood, toxins—especially ammonia—build up and affect brain function. Symptoms range from subtle cognitive changes (minimal HE) to confusion, personality changes, sleep disturbances, and in severe cases, coma. HE typically occurs in people with cirrhosis, especially after a precipitating event like infection, GI bleeding, constipation, or medication changes.

CRITICAL: Hepatic encephalopathy requires medical management. Standard treatment includes lactulose and/or rifaximin to reduce ammonia. This protocol is ADJUNCTIVE to standard therapy, not a replacement. Acute HE requires immediate medical attention.

•L-Ornithine L-Aspartate (LOLA) is the most studied supplement for HE. It provides substrates for ammonia detoxification—ornithine activates urea cycle enzymes, while aspartate provides a carbon skeleton for glutamine synthesis. Meta-analyses show LOLA significantly reduces ammonia levels and improves mental status. Standard L-carnitine may provide some similar benefits through enhanced energy metabolism and neuroprotection.
•Branched-Chain Amino Acids (BCAAs) help correct the amino acid imbalance seen in liver disease. Normally, BCAAs and aromatic amino acids (AAAs) compete for brain entry. In liver disease, AAA levels rise, increasing neurotoxic substances in the brain. BCAA supplementation helps restore this balance and may improve mental function.
•Zinc is a cofactor for two key urea cycle enzymes that convert ammonia to urea. Zinc deficiency is extremely common in cirrhosis (due to poor absorption, increased losses, and dietary restrictions). Supplementation can help reduce ammonia levels and may improve HE.
•Probiotics target the gut—a major source of ammonia from bacterial metabolism of protein. They can reduce ammonia-producing bacteria, strengthen the gut barrier (reducing bacterial translocation), and decrease systemic inflammation. Studies show probiotics can prevent and treat HE.
•Resveratrol is a powerful antioxidant that may protect brain cells from the oxidative stress caused by ammonia and other toxins. It also has anti-inflammatory effects that may help reduce the systemic inflammation that contributes to HE.
•Vitamin D deficiency is nearly universal in cirrhosis and is associated with worse liver disease outcomes. Vitamin D affects brain function through multiple mechanisms. Correcting deficiency may support overall health and potentially cognitive function.
•Omega-3 Fatty Acids have anti-inflammatory effects that may help reduce the systemic inflammation contributing to HE. They may also support brain membrane function.

Expected timeline: LOLA effects: within days to weeks for acute episodes. Zinc: 2-4 weeks to correct deficiency. Probiotics: 2-4 weeks for gut effects. These supplements support standard HE therapy and ongoing liver disease management.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

A
Ammonia
Moderate Decrease
5 studies
moderate↓Improves
?
Hepatic Encephalopathy Symptoms
5 studies
↓Improves
?
Attention
2 studies
↑Improves
?
Anxiety Symptoms
1 study
↓Improves
?
Bilirubin
1 study
↑Worsens
?
Cirrhosis Severity
1 study
↑Worsens
?
Cognition
1 study
↑Improves
?
Depression Symptoms
1 study
↓Improves
?
Liver Enzymes
1 study
↑Worsens
?
Serum Albumin
1 study
↑Improves
?
Urea
1 study
↑Improves
B
Blood Urea Nitrogen (BUN)
Small Decrease
17 studies
small↓Improves
?
Serum Albumin
10 studies
↑Improves
?
Uric Acid
4 studies
↓Improves
?
Kidney Function
3 studies
↑Improves

Related Conditions

Type 2 Diabetes

2 shared supplements · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Type 1 Diabetes

2 shared supplements · 76 outcomes

Type 1 diabetes is an autoimmune disease in which the pancreas stops producing insulin. It can begin at any age, although most commonly in childhood or adolescence, and requires life-long treatment with insulin.

Prediabetes

2 shared supplements · 144 outcomes

Prediabetes is the intermediate stage between healthy blood glucose levels and diabetes. It is associated with an increased risk of cardiovascular disease and type 2 diabetes. Weight loss induced by lifestyle intervention is the primary treatment and is very effective.

Polycystic Ovary Syndrome (PCOS)

2 shared supplements · 220 outcomes

Polycystic ovary syndrome (PCOS) is a hormone disorder that is common among women of reproductive age. PCOS is often caused by high androgen levels and frequently involves infertility, cysts on the ovaries, and metabolic abnormalities.

Peripheral Arterial Disease

2 shared supplements · 39 outcomes

Peripheral arterial disease is a condition characterized by a narrowing of the arteries that carry blood away from the heart to other parts of the body. It is usually caused by atherosclerosis. The legs and feet are most commonly affected, resulting in reduced blood flow to these areas.

Overweight

2 shared supplements · 379 outcomes

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).

Osteoarthritis (OA)

2 shared supplements · 116 outcomes

Osteoarthritis (OA) is a joint disease involving cartilage degradation. It’s not clear what exactly causes OA, but some risk factors include joint injury, overweight or obesity, aging, misaligned joints, and family history. Lots of supplements have been studied in people with OA, as have lifestyle interventions including weight loss and exercise.

Obesity

2 shared supplements · 525 outcomes

Obesity is a condition of excessive body fat that increases the risk for other conditions such as diabetes and heart disease. Fat is how the body stores extra calories that were eaten but not used. Obesity treatment usually involves restricting the calories eaten or creating a negative calorie balance.